FGF-19, A NOVEL FIBROBLAST GROWTH FACTOR WITH UNIQUE SPECIFICITY FOR FGFR4

Slavin, 1995, Fibroblast growth factors: at the heart of angiogenesis, Cell Biol Int, 19, 431, 10.1006/cbir.1995.1087

Goldfarb, 1996, Functions of fibroblast growth factors in vertebrate development, Cytokine Growth Factor Rev, 7, 311, 10.1016/S1359-6101(96)00039-1

Naski, 1998, FGF signaling in skeletal development (In process Citation), Front Biosci, 3, D781, 10.2741/A321

Mathieu, 1995, Receptor binding and mitogenic properties of mouse fibroblast growth factor 3. Modulation of response by heparin, J Biol Chem, 270, 24197, 10.1074/jbc.270.41.24197

Ornitz, 1996, Receptor specificity of the fibroblast growth factor family, J Biol Chem, 271, 15292, 10.1074/jbc.271.25.15292

Ornitz, 1992, Ligand specificity and heparin dependence of fibroblast growth factor receptors 1 and 3, J Biol Chem, 267, 16305, 10.1016/S0021-9258(18)42001-7

Santos-Ocampo, 1996, Expression and biological activity of mouse fibroblast growth factor-9, J Biol Chem, 271, 1726, 10.1074/jbc.271.3.1726

Moscatelli, 1987, High and low affinity binding sites for basic fibroblast growth factor on cultured cells: absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells, J Cell Physiol, 131, 123, 10.1002/jcp.1041310118

Folkman, 1988, A heparin-binding angiogenic protein—basic fibroblast growth factor—is stored within basement membrane, Am J Pathol, 130, 393

Saksela, 1988, Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation, J Cell Biol, 107, 743, 10.1083/jcb.107.2.743

Bashkin, 1989, Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules, Biochemistry, 28, 1737, 10.1021/bi00430a047

Ornitz, 1992, Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells, Mol Cell Biol, 12, 240, 10.1128/MCB.12.1.240

Herr, 1997, Heparin-induced self-association of fibroblast growth factor-2. Evidence for two oligomerization processes, J Biol Chem, 272, 16382, 10.1074/jbc.272.26.16382

Mach, 1993, Nature of the interaction of heparin with acidic fibroblast growth factor, Biochemistry, 32, 5480, 10.1021/bi00071a026

Kiefer, 1991, The molecular biology of heparan sulfate fibroblast growth factor receptors, Ann NY Acad Sci, 638, 167, 10.1111/j.1749-6632.1991.tb49027.x

Aviezer, 1994, Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis, Cell, 79, 1005, 10.1016/0092-8674(94)90031-0

Johnson, 1991, The human fibroblast growth factor receptor genes: a common structural arrangement underlies the mechanisms for generating receptor forms that differ in their third immunoglobulin domain, Mol Cell Biol, 11, 4627, 10.1128/MCB.11.9.4627

Murgue, 1994, Identification of a novel variant form of fibroblast growth factor receptor 3 (FGFR3 IIIb) in human colonic epithelium, Cancer Res, 54, 5206

Perez-Castro, 1995, Genomic organization of the mouse fibroblast growth factor receptor 3 (Fgfr3) gene, Genomics, 30, 157, 10.1006/geno.1995.9890

Dell, 1992, A novel form of fibroblast growth factor receptor 2. Alternative splicing of the third immunoglobulin-like domain confers ligand binding specificity, J Biol Chem, 267, 21225, 10.1016/S0021-9258(19)36821-8

Partanen, 1991, FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern, EMBO J, 10, 1347, 10.1002/j.1460-2075.1991.tb07654.x

Armstrong, 1992, Expression of fibroblast growth factor receptors in human leukemia cells, Cancer Res, 52, 2004

Ron, 1993, Fibroblast growth factor receptor 4 is a high affinity receptor for both acidic and basic fibroblast growth factor but not for keratinocyte growth factor, J Biol Chem, 268, 5388, 10.1016/S0021-9258(18)53334-2

Vainikka, 1992, Fibroblast growth factor receptor-4 shows novel features in genomic structure, ligand binding and signal transduction [published erratum appears in EMBO J 1993 Feb; 12 (2): 810], EMBO J, 11, 4273, 10.1002/j.1460-2075.1992.tb05526.x

Wang, 1994, Fibroblast growth factor receptors have different signaling and mitogenic potentials, Mol Cell Biol, 14, 181, 10.1128/MCB.14.1.181

Shaoul, 1995, Fibroblast growth factor receptors display both common and distinct signaling pathways, Oncogene, 10, 1553

Vainikka, 1994, Signal transduction by fibroblast growth factor receptor-4 (FGFR-4). Comparison with FGFR-1, J Biol Chem, 269, 18320, 10.1016/S0021-9258(17)32309-8

Vainikka, 1996, Association of a 85-kDa serine kinase with activated fibroblast growth factor receptor-4, J Biol Chem, 271, 1270, 10.1074/jbc.271.3.1270

Abbass, 1997, Altered expression of fibroblast growth factor receptors in human pituitary adenomas, J Clin Endocrinol Metab, 82, 1160, 10.1210/jcem.82.4.3896

McLeskey, 1994, MDA-MB-134 breast carcinoma cells overexpress fibroblast growth factor (FGF) receptors and are growth-inhibited by FGF ligands, Cancer Res, 54, 523

Penault-Llorca, 1995, Expression of FGF and FGF receptor genes in human breast cancer, Int J Cancer, 61, 170, 10.1002/ijc.2910610205

Johnston, 1995, bFGF and aFGF induce membrane ruffling in breast cancer cells but not in normal breast epithelial cells: FGFR-4 involvement, Biochem J, 306, 609, 10.1042/bj3060609

Webster, 1997, FGFR activation in skeletal disorders: too much of a good thing, Trends in Genetics, 13, 178, 10.1016/S0168-9525(97)01131-1

Wilkie, 1997, Craniosynostosis: genes and mechanisms, Hum Mol Genet, 6, 1647, 10.1093/hmg/6.10.1647

Frontali, 1985, Osteoporosis-pseudoglioma syndrome: report of three affected sibs and an overview, Am J Med Genet, 22, 35, 10.1002/ajmg.1320220104

Somer, 1988, Osteoporosis-pseudoglioma syndrome: clinical, morphological, and biochemical studies, J Med Genet, 25, 543, 10.1136/jmg.25.8.543

Gong, 1996, Osteoporosis-pseudoglioma syndrome, a disorder affecting skeletal strength and vision, is assigned to chromosome region 11q12–13, Am J Hum Genet, 59, 146

Johnson, 1997, Linkage of a gene causing high bone mass to human chromosome 11 (11q12–13), Am J Hum Genet, 60, 1326, 10.1086/515470

McWhirter, 1997, A novel fibroblast growth factor gene expressed in the developing nervous system is a downstream target of the chimeric homeodomain oncoprotein E2A-Pbx1, Development, 124, 3221, 10.1242/dev.124.17.3221

Xie, 1997, Direct demonstration of MuSK involvement in acetylcholine receptor clustering through identification of agonist ScFcv, Nat Biotechnol, 15, 768, 10.1038/nbt0897-768